AU Patent

AU2019200828B2 — Modulation of complement activity

Assigned to UCB Holdings Inc · Expires 2021-04-08 · 5y expired

What this patent protects

The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics. 10838884_1 (GHMatters) P104653.AU.1 14/11/18 7/7 coO Dcz @0 CN f-Jt cm t20 0 0) N Q QJ CD LO sis~lwOHI

USPTO Abstract

The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics. 10838884_1 (GHMatters) P104653.AU.1 14/11/18 7/7 coO Dcz @0 CN f-Jt cm t20 0 0) N Q QJ CD LO sis~lwOHI

Drugs covered by this patent

Patent Metadata

Patent number
AU2019200828B2
Jurisdiction
AU
Classification
—
Expires
2021-04-08
Drug substance claim
No
Drug product claim
No
Assignee
UCB Holdings Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.